EichorEICHOR
Study identifier: NCT07585773 Synced from ClinicalTrials.gov · August 04, 2026
● Not Yet Recruiting

Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)

Condition: Cirrhosis · Splenectomy; Status · Hypersplenism  ·  Sponsor: Northern Jiangsu People's Hospital

PhaseN/A
Planned participants30
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Patients with liver cirrhosis often have impaired or at-risk kidney function due to the close link between liver and kidney (hepatorenal syndrome). Laparoscopic splenectomy is commonly used to treat splenomegaly and hypersplenism in these patients, but its impact on kidney function over 2 years is unclear. This study will follow patients undergoing laparoscopic splenectomy to measure changes in kidney function before and after surgery, identify risk factors for kidney damage and whether laparoscopic splenectomy can improve kidney function in the long term, and help improve care to protect kidney function in cirrhotic patients .

This description comes directly from the study's public registry record.

Talk to the study team

Guo-Qing Jiang, MD  ·  +8651487373272  ·  jgqing2003@hotmail.com

Dou-Sheng Bai, MD  ·  +8651487373372  ·  bdsno1@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Clinical Medical College of Yangzhou UniversityYangzhou, Jiangsu, China

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →